We are live on ! Find out more
DSI

Daiwa SB Investments Portfolio holdings

AUM $506M
1-Year Est. Return 11%
This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+11%
3 Year Est. Return
+60.53%
5 Year Est. Return
+93.17%
10 Year Est. Return
AUM
$428M
AUM Growth
-$9.28M
Cap. Flow
-$30M
Cap. Flow %
-6.99%
Top 10 Hldgs %
31.08%
Holding
183
New
13
Increased
24
Reduced
82
Closed
54

Top Sells

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$8.54M
2
LLY icon
Eli Lilly
LLY
+$8.46M
3
HAS icon
Hasbro
HAS
+$8.42M
4
ABBV icon
AbbVie
ABBV
+$8.25M
5
GIS icon
General Mills
GIS
+$8.23M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.39%
2 Financials 14.31%
3 Healthcare 12.07%
4 Consumer Staples 11.95%
5 Technology 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BF.B icon
26
Brown-Forman Class B
BF.B
$12.9B
$8.31M 1.94%
261,634
-5,210
-2% -$174K
NWL icon
27
Newell Brands
NWL
$2.51B
$8.29M 1.93%
188,090
-22,350
-11% -$978K
DD icon
28
DuPont de Nemours
DD
$19.1B
$7.84M 1.83%
60,140
-2,156
-3% -$277K
LMT icon
29
Lockheed Martin
LMT
$139B
$7.83M 1.83%
36,060
T icon
30
AT&T
T
$165B
$7.71M 1.8%
296,841
+286,832
+2,866% +$7.28M
TD icon
31
Toronto Dominion Bank
TD
$200B
$7.24M 1.69%
184,880
BNS icon
32
Scotiabank
BNS
$108B
$6.63M 1.55%
167,532
-2,112
-1% -$91.2K
BABA icon
33
Alibaba
BABA
$317B
$3.04M 0.71%
37,350
+32,700
+703% +$2.57M
CELG
34
DELISTED
Celgene Corp
CELG
$3.01M 0.7%
25,169
-11,545
-31% -$1.34M
META icon
35
Meta Platforms (Facebook)
META
$1.52T
$2.98M 0.7%
28,503
-14,259
-33% -$1.46M
XOM icon
36
ExxonMobil
XOM
$662B
$2.68M 0.63%
34,423
-3,488
-9% -$279K
GILD icon
37
Gilead Sciences
GILD
$165B
$2.66M 0.62%
26,293
-2,387
-8% -$248K
ELV icon
38
Elevance Health
ELV
$86.2B
$2.62M 0.61%
18,810
-3,044
-14% -$419K
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.35T
$2.51M 0.59%
66,200
-84,840
-56% -$3.04M
GOOGL icon
40
Alphabet (Google) Class A
GOOGL
$4.37T
$2.49M 0.58%
+64,040
New +$2.37M
LUV icon
41
Southwest Airlines
LUV
$22B
$2.32M 0.54%
53,860
-6,878
-11% -$305K
C icon
42
Citigroup
C
$227B
$2.13M 0.5%
41,168
-22,289
-35% -$1.18M
MRSH
43
Marsh
MRSH
$91B
$2.06M 0.48%
37,132
-3,868
-9% -$213K
AMGN icon
44
Amgen
AMGN
$226B
$2.04M 0.48%
12,562
-1,659
-12% -$261K
MHK icon
45
Mohawk Industries
MHK
$9.19B
$1.91M 0.45%
10,104
-2,127
-17% -$408K
NTRS icon
46
Northern Trust
NTRS
$34.4B
$1.89M 0.44%
26,197
-2,087
-7% -$150K
HRL icon
47
Hormel Foods
HRL
$13.6B
$1.84M 0.43%
46,484
-8,492
-15% -$302K
KR icon
48
Kroger
KR
$34.6B
$1.82M 0.43%
43,527
-4,042
-8% -$157K
BIIB icon
49
Biogen
BIIB
$30.6B
$1.78M 0.42%
5,812
-1,257
-18% -$361K
NDAQ icon
50
Nasdaq
NDAQ
$53.4B
$1.66M 0.39%
85,545
+17,685
+26% +$337K

Similar funds

Daiwa SB Investments's Q4 2015 Portfolio in Review

As of Q4 2015, Daiwa SB Investments held 183 positions worth $428M, down 2.1% from $438M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa SB Investments withdrew a net $30M in Q4 2015, closing 54 positions and reducing 82 holdings. Its most notable exit was Kimberly-Clark, an estimated $8.54M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Daiwa SB Investments opened a new position in iShares MSCI Emerging Markets ETF worth $27.7M.

  • Daiwa SB Investments's largest Q4 2015 buy was iShares MSCI Emerging Markets ETF: 861,613 shares worth $27.7M.
  • Daiwa SB Investments added most to State Street SPDR S&P 500 ETF Trust in Q4 2015, an estimated $14.6M increase.
  • Daiwa SB Investments's biggest Q4 2015 reduction was Eli Lilly, cutting an estimated $8.46M.
  • Daiwa SB Investments fully exited Kimberly-Clark in Q4 2015, selling an estimated $8.54M.
  • Daiwa SB Investments's ten largest holdings make up 31% of its $428M portfolio in Q4 2015.
  • Daiwa SB Investments opened 13 new positions and closed 54 in Q4 2015.
  • Daiwa SB Investments's portfolio value fell 2.1% quarter-over-quarter to $428M.

Based on Daiwa SB Investments's 13F filing for Q4 2015, filed 8 Jan 2016.